Ko, M.-Y.; Hsu, Y.-C.; Yen, H.-H.; Huang, S.-P.; Su, P.-Y.
The Effects of Pangenotypic Direct-Acting Antiviral Therapy on Lipid Profiles and Insulin Resistance in Chronic Hepatitis C Patients. Viruses 2025, 17, 263.
https://doi.org/10.3390/v17020263
AMA Style
Ko M-Y, Hsu Y-C, Yen H-H, Huang S-P, Su P-Y.
The Effects of Pangenotypic Direct-Acting Antiviral Therapy on Lipid Profiles and Insulin Resistance in Chronic Hepatitis C Patients. Viruses. 2025; 17(2):263.
https://doi.org/10.3390/v17020263
Chicago/Turabian Style
Ko, Meng-Yu, Yu-Chung Hsu, Hsu-Heng Yen, Siou-Ping Huang, and Pei-Yuan Su.
2025. "The Effects of Pangenotypic Direct-Acting Antiviral Therapy on Lipid Profiles and Insulin Resistance in Chronic Hepatitis C Patients" Viruses 17, no. 2: 263.
https://doi.org/10.3390/v17020263
APA Style
Ko, M.-Y., Hsu, Y.-C., Yen, H.-H., Huang, S.-P., & Su, P.-Y.
(2025). The Effects of Pangenotypic Direct-Acting Antiviral Therapy on Lipid Profiles and Insulin Resistance in Chronic Hepatitis C Patients. Viruses, 17(2), 263.
https://doi.org/10.3390/v17020263